|

Folinic acid Clinical Trials

7 actively recruiting trials across 2 locations

No change since July 2026

Also known as: Folinic Acid IV, Leucovorin

Pipeline

Phase 2: 3Phase 3: 3

Top Sponsors

  • Fudan University2
  • Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins1
  • IFOM ETS - The AIRC Institute of Molecular Oncology1
  • Federation Francophone de Cancerologie Digestive1
  • Astellas Pharma Global Development, Inc.1

Indications

  • Cancer7
  • Small Intestinal Carcinoma1
  • Carcinoma of Unknown Primary With Gastrointestinal Profile1
  • Liver Disease1
  • Appendix Carcinoma1

Other5 trials

A Study of ASP2138 Together With Chemotherapy and Pembrolizumab in Adults With Gastric Cancer
Phase 3
Hypofractionated Radiotherapy Plus Immunotherapy Versus Conventional Radiotherapy in Locally Recurrent Rectal Cancer
Phase 2
Systemic Oxaliplatin or Intra-arterial Chemotherapy Combined With LV5FU2 +/- Irinotecan and an Target Therapy in First Line Treatment of Metastatic Colorectal Cancer Restricted to the Liver
Phase 3
The Combination of Hypofractionated Radiotherapy and Immunotherapy in Locally Recurrent Rectal Cancer
Phase 2
The Sagittarius Trial
Phase 3

Fairbanks, Alaska1 trial

Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays

Fairbanks Memorial Hospital

N/A

Baltimore, Maryland1 trial

NC410 and FOLFIRINOX in Combination With Nivolumab With or Without Ipilimumab in Patients With Untreated Metastatic Pancreatic Cancer

Sidney Kimmel Comprehensive Cancer Center

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.